검색어 : 통합검색[Swanson Cooper]
총 192건 중 192건 출력
, 18/20 페이지
-
171
- Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds
- Sher, Lawrence D; Boakye-Appiah, Justice K; Hill, Sungeen; Wasserman, Emily; Xu, Xia; Maldonado, Yvonne; Walter, Emmanuel B; Muñ oz, Flor M; Paulsen, Grant C; Englund, Janet A; Talaat, Kawsar R; Barnett, Elizabeth D; Kamidani, Satoshi; Senders, Shelly; Simõ es, Eric A F; Belanger, Kelly; Parikh, Vrunda; Ma, Hua; Wang, Xingbin; Lu, Claire; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S; Tü reci, Ö zlem; Ş ahin, Uğ ur; Swanson, Kena A; Gruber, William C; Gurtman, Alejandra; Kitchin, Nicholas; Sabharwal, Charu; Peninsula Research Associates , Rolling Hills Estates, California , USA; Vaccine Research and Development, Pfizer Ltd , Hurley , UK; Vaccine Research and Development, Pfizer Ltd , Hurley , UK; Vaccine Research and Development, Pfizer Inc , Pearl River, New York , USA; Vaccine Research and Development, Pfizer Inc , Collegeville, Pennsylvania , USA; Pediatric Infectious Disease, Stanford University School of Medicine , Palo Alto, California , USA; Duke Human Vaccine Institute , Duke University School of Medicine, Durham, North Carolina , USA; Pediatrics Infectious Disease, Texas Children’s Hospital, Baylor College of Medicine , Houston, Texas , USA; Department of Pediatrics, University of Cincinnati College of Medicine and Division of Pediatric Infectious Diseases, Cincinnati Children’s Hospital Medical Center , Cincinnati, Ohio , USA; Department of Pediatrics, Seattle Children’s Hospital , Seattle, Washington , USA; International Health, Johns Hopkins University , Baltim; (Journal of the Pediatric Infectious Diseases Society, v.13, 2024, pp.421-429)
-
172
- Plain Language Summary of Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Safety in Participants at Least 16 Years Old and Protection Against COVID-19 in Participants at Least 12 Years Old
- Thomas, Stephen J; Moreira, Edson D; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Perez, John L; Marc, Gonzalo Pé rez; Polack, Fernando P; Zerbini, Cristiano; Bailey, Ruth; Swanson, Kena A; Xu, Xia; Roychoudhury, Satrajit; Koury, Kenneth; Bouguermouh, Salim; Kalina, Warren V; Cooper, David; Frenck, Robert W; Hammitt, Laura L; Tü reci, Ö zlem; Nell, Haylene; Schaefer, Axel; Ü nal, Serhat; Yang, Qi; Liberator, Paul; Tresnan, Dina B; Mather, Susan; Dormitzer, Philip R; Ş ahin, Uğ ur; Gruber, William C; Jansen, Kathrin U; State University of New York Upstate Medical University Syracuse NY USA; Associaç ã o Obras Sociais Irmã Dulce & Oswaldo Cruz Foundation Bahia Brazil; Vaccine Research & Development Pfizer Hurley UK; Vaccine Research & Development Pfizer Pearl River NY USA; Vaccine Research & Development Pfizer Pearl River NY USA; Vaccine Research & Development Pfizer Hurley UK; Worldwide Safety Safety Surveillance & Risk Management Pfizer Collegeville PA USA; iTrials-Hospital Militar Central Buenos Aires Pernambuco Brazil; Fundacion INFANT Buenos Aires Pernambuco Brazil; Centro Paulista de Investigaç ã o Clinica Sã o Paulo Brazil; Vaccine Research & Development Pfizer Hurley UK; Vaccine Research & Development Pfizer Pearl River NY USA; Vaccine Research & Development Pfizer Collegeville PA USA; Global Product Development Pfizer Peapack NJ USA; Vaccine Research & Development Pfizer Pearl River NY USA; Vaccine Research & Development Pfizer Pearl River N; (Future virology, v.17, 2022, pp.849-862)
-
173
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- Thomas, Stephen J.; Moreira Jr., Edson D.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Perez, John L.; Pé rez Marc, Gonzalo; Polack, Fernando P.; Zerbini, Cristiano; Bailey, Ruth; Swanson, Kena A.; Xu, Xia; Roychoudhury, Satrajit; Koury, Kenneth; Bouguermouh, Salim; Kalina, Warren V.; Cooper, David; Frenck Jr., Robert W.; Hammitt, Laura L.; Tü reci, Ö zlem; Nell, Haylene; Schaefer, Axel; Ü nal, Serhat; Yang, Qi; Liberator, Paul; Tresnan, Dina B.; Mather, Susan; Dormitzer, Philip R.; Ş ahin, Uğ ur; Gruber, William C.; Jansen, Kathrin U.; From the State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., S.B., W.V.K., D.C., Q.Y., P.L., P.R.D., W.C.G., K.U.J.) - both in New York; Associaç ã o Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and iTrials-Hospital Militar Central (G.P.M.) and Fundacion INFANT, Buenos Aires (F.P.P.) - all in Brazil; Centro Paulista de Investigaç ã o Clinica, Sã o Paulo (C.Z.); Vaccine...; From the State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., S.B., W.V.K., D.C., Q.Y., P.L., P.R.D., W.C.G., K.U.J.) - both in New York; Associaç ã o Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and iTrials-Hospital Militar Central (G.P.M.) and Fundacion INFANT, Buenos Aires (F.P.P.) - all in Bra; (The New England journal of medicine, v.385, 2021, pp.1761-1773)
-
174
- Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
- Moreira Jr., Edson D.; Kitchin, Nicholas; Xu, Xia; Dychter, Samuel S.; Lockhart, Stephen; Gurtman, Alejandra; Perez, John L.; Zerbini, Cristiano; Dever, Michael E.; Jennings, Timothy W.; Brandon, Donald M.; Cannon, Kevin D.; Koren, Michael J.; Denham, Douglas S.; Berhe, Mezgebe; Fitz-Patrick, David; Hammitt, Laura L.; Klein, Nicola P.; Nell, Haylene; Keep, Georgina; Wang, Xingbin; Koury, Kenneth; Swanson, Kena A.; Cooper, David; Lu, Claire; Tü reci, Ö zlem; Lagkadinou, Eleni; Tresnan, Dina B.; Dormitzer, Philip R.; Ş ahin, Uğ ur; Gruber, William C.; Jansen, Kathrin U.; From Associaç ã o Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigaç ã o Clinica, Sã o Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.)...; From Associaç ã o Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigaç ã o Clinica, Sã o Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Resea; (The New England journal of medicine, v.386, 2022, pp.1910-1921)
-
175
- Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults
- Athan, Eugene; Baber, James; Quan, Karen; Scott, Robert J; Jaques, Anna; Jiang, Qin; Li, Wen; Cooper, David; Cutler, Mark W; Kalinina, Elena V; Anderson, Annaliesa S; Swanson, Kena A; Gruber, William C; Gurtman, Alejandra; Schmoele-Thoma, Beate; Argent, Christopher; Arya, Mark; Athan, Eugene; Bird, Paul; Bloch, Mark; Bull, Sheetal; Colquhoun, David; De Silva, Gustinna; Deshmukh, Sachin; Eizenberg, Peter; Gilfillan, Christopher; Gunner, Elizabeth; Hiew, Valerie; Leah, Amber; Leelasena, Indika; Lickliter, Jason; McGirr, Anthony; Mohan, Rahul; Morbey, Claire; Murdoch, Louise; Nelson, Mark; Neville, A Munro; O'Sullivan, Matthew; Rook, Christopher; Russo, Marc; Ryan, Philip; Scott, Robert; Tai, Sze; Tiong, Florence; Voloshyna, Olga; Wark, Peter; Barwon Health, Deakin University , Geelong, Victoria , Australia; Vaccine Clinical Research, Pfizer Australia Pty Ltd , Sydney, New South Wales , Australia; Vaccine Clinical Research, Pfizer Australia Pty Ltd , Sydney, New South Wales , Australia; USC Clinical Trials , Sippy Downs, Queensland , Australia; Vaccine Clinical Research, Pfizer Australia Pty Ltd , Sydney, New South Wales , Australia; Pfizer Vaccine Research and Development , Collegeville, Pennsylvania , USA; Pfizer Vaccine Research and Development , Collegeville, Pennsylvania , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vaccine Research and Development , Pearl River, New York , USA; Pfizer Vacc; (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, v.78, 2024, pp.1360-1368)
-
176
- Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
- Muñ oz, Flor M.; Sher, Lawrence D.; Sabharwal, Charu; Gurtman, Alejandra; Xu, Xia; Kitchin, Nicholas; Lockhart, Stephen; Riesenberg, Robert; Sexter, Joanna M.; Czajka, Hanna; Paulsen, Grant C.; Maldonado, Yvonne; Walter, Emmanuel B.; Talaat, Kawsar R.; Englund, Janet A.; Sarwar, Uzma N.; Hansen, Caitlin; Iwamoto, Martha; Webber, Chris; Cunliffe, Luke; Ukkonen, Benita; Martí nez, Silvina N.; Pahud, Barbara A.; Munjal, Iona; Domachowske, Joseph B.; Swanson, Kena A.; Ma, Hua; Koury, Kenneth; Mather, Susan; Lu, Claire; Zou, Jing; Xie, Xuping; Shi, Pei-Yong; Cooper, David; Tü reci, Ö zlem; Ş ahin, Uğ ur; Jansen, Kathrin U.; Gruber, William C.; From Texas Children’s Hospital, Baylor College of Medicine, Houston (F.M.M.), and the University of Texas Medical Branch, Galveston (J.Z., X. Xie, P.-Y.S.); Peninsula Research Associates, Rolling Hills Estates (L.D.S.), and Stanford University School of Medicine, Palo Alto (Y.M.) - both in California; Vaccine Research and Development, Pfizer, Pearl River (C.S., A.G., U.N.S., C.H., M.I., B.A.P., I.M., K.A.S., K.K., C.L., D.C., K.U.J., W.C.G.), and SUNY Upstate Medical University, Syracuse (J.B.D.) -...; From Texas Children’s Hospital, Baylor College of Medicine, Houston (F.M.M.), and the University of Texas Medical Branch, Galveston (J.Z., X. Xie, P.-Y.S.); Peninsula Research Associates, Rolling Hills Estates (L.D.S.), and Stanford University School of Medicine, Palo Alto (Y.M.) - both in California; Vaccine Research and Development, Pfizer, Pearl River (C.S., A.G., U.N.S., C.H., M.I., B.A.P., I.M., K.A.S., K.K., C.L., D.C., K.U.J., W.C.G.), and SUNY Upstate Medical University, Syr; (The New England journal of medicine, v.388, 2023, pp.621-634)
-
177
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
- Walter, Emmanuel B.; Talaat, Kawsar R.; Sabharwal, Charu; Gurtman, Alejandra; Lockhart, Stephen; Paulsen, Grant C.; Barnett, Elizabeth D.; Muñ oz, Flor M.; Maldonado, Yvonne; Pahud, Barbara A.; Domachowske, Joseph B.; Simõ es, Eric A.F.; Sarwar, Uzma N.; Kitchin, Nicholas; Cunliffe, Luke; Rojo, Pablo; Kuchar, Ernest; Rä met, Mika; Munjal, Iona; Perez, John L.; Frenck Jr., Robert W.; Lagkadinou, Eleni; Swanson, Kena A.; Ma, Hua; Xu, Xia; Koury, Kenneth; Mather, Susan; Belanger, Todd J.; Cooper, David; Tü reci, Ö zlem; Dormitzer, Philip R.; Ş ahin, Uğ ur; Jansen, Kathrin U.; Gruber, William C.; From Duke Human Vaccine Institute, Durham, NC (E.B.W.); Johns Hopkins University, Baltimore (K.R.T.); Vaccine Research and Development, Pfizer, Pearl River (C.S., A.G., B.A.P., U.N.S., I.M., K.A.S., K.K., T.J.B., D.C., P.R.D., K.U.J., W.C.G.), and SUNY Upstate Medical University, Syracuse (J.B.D.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (S.L., N.K., L.C.); the Department of Pediatrics, University of Cincinnati College of Medicine and the Division of...; From Duke Human Vaccine Institute, Durham, NC (E.B.W.); Johns Hopkins University, Baltimore (K.R.T.); Vaccine Research and Development, Pfizer, Pearl River (C.S., A.G., B.A.P., U.N.S., I.M., K.A.S., K.K., T.J.B., D.C., P.R.D., K.U.J., W.C.G.), and SUNY Upstate Medical University, Syracuse (J.B.D.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (S.L., N.K., L.C.); the Department of Pediatrics, University of Cincinnati College of Medicine and the Division; (The New England journal of medicine, v.386, 2022, pp.35-46)
-
178
- Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M.; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian; Lö rks, Verena; Sikorski, Julian; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grü tzner, Jan; Boesler, Carsten; Rosenbaum, Corinna; Kü hnle, Marie-Cristine; Luxemburger, Ulrich; Kemmer-Brü ck, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Karikó , Katalin; Palanche, Tania; Fischer, Boris; Schultz, Armin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L.; Swanson, Kena A.; Loschko, Jakob; Scully, Ingrid L.; Cutler, Mark; Kalina, Warren; Kyratsous, Christos A.; Cooper, David; Dormitzer, Philip R.; Jansen, Kathrin U.; Tü reci, Ö zlem; ; (Nature, v.590, 2021, pp.E17-E17)
-
179
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M.; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian; Lö rks, Verena; Sikorski, Julian; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grü tzner, Jan; Boesler, Carsten; Rosenbaum, Corinna; Kü hnle, Marie-Cristine; Luxemburger, Ulrich; Kemmer-Brü ck, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Karikó , Katalin; Palanche, Tania; Fischer, Boris; Schultz, Armin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L.; Swanson, Kena A.; Loschko, Jakob; Scully, Ingrid L.; Cutler, Mark; Kalina, Warren; Kyratsous, Christos A.; Cooper, David; Dormitzer, Philip R.; Jansen, Kathrin U.; Tü reci, Ö zlem; ; (Nature, v.586, 2020, pp.594-599)
-
180
- Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial
- Simõ es, Eric A. F.; Pahud, Barbara A.; Madhi, Shabir A.; Kampmann, Beate; Shittu, Emma; Radley, David; Llapur, Conrado; Baker, Jeffrey; Pé rez Marc, Gonzalo; Barnabas, Shaun L.; Fausett, Merlin; Adam, Tyler; Perreras, Nicole; Van Houten, Marlies A.; Kantele, Anu; Huang, Li-Min; Bont, Louis J.; Otsuki, Takeo; Vargas, Sergio L.; Gullam, Joanna; Tapiero, Bruce; Stein, Renato T.; Polack, Fernando P.; Zar, Heather J.; Staerke, Nina B.; Padilla, Marí a Duron; Richmond, Peter C.; Sarwar, Uzma N.; Baber, James; Koury, Kenneth; Lino, Maria Maddalena; Kalinina, Elena V.; Li, Weiqiang; Cooper, David; Anderson, Annaliesa S.; Swanson, Kena A.; Gurtman, Alejandra; Munjal, Iona; ; (Obstetrics and gynecology, v.145, 2025, pp.157-167)
QUICK MENU
